The conference is on cancer vaccines.
In PYC's poster it shows work on melanoma cells:
ª Phylomer delivered peptide vaccine slows outgrowth of experimental B16 melanoma
ª Subcutaneous B16 melanoma model engineered to express HSVderived gB antigen present in the vaccine construct
Interesting to see Ira Mellman (Genentech) is at the conference.
http://www.keystonesymposia.org/19L2
Ann: Conference Presentation - Keystone Symposia Vancouver, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.5¢ | $99.01K | 931.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1170606 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 1088634 | 9 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |